Anika Therapeutics
ANIK
#8729
Rank
A$0.27 B
Marketcap
A$20.54
Share price
-2.10%
Change (1 day)
17.63%
Change (1 year)
Categories

Anika Therapeutics (ANIK) - P/B ratio

P/B ratio as of June 2026 : 1.33

According to Anika Therapeutics's latest financial reports the company has a price-to-book ratio of 2.41154.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Anika Therapeutics - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-310.9185-40.53%
2024-12-311.54-1.18%
2023-12-311.563.21%
2022-12-311.51-15.98%
2021-12-311.80-24.3%
2020-12-312.38-7.45%
2019-12-312.5741.99%
2018-12-311.81-39.6%
2017-12-313.00-6.66%
2016-12-313.2118.09%
2015-12-312.72-19.9%
2014-12-313.40-15.49%
2013-12-314.02217.72%
2012-12-311.27-10.2%
2011-12-311.4133.48%
2010-12-311.06-15.31%
2009-12-311.25118.85%
2008-12-310.5695-80.83%
2007-12-312.97-5.46%
2006-12-313.14-2.99%
2005-12-313.244.57%
2004-12-313.10-42.72%
2003-12-315.41838.41%
2002-12-310.5764

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
6.91 420.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
2.14 61.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
5.25 294.66%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
4.30 223.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
173 12,888.96%๐Ÿ‡บ๐Ÿ‡ธ USA